Peapod Lane Capital LLC Atea Pharmaceuticals, Inc. Transaction History
Peapod Lane Capital LLC
- $99.9 Billion
- Q2 2025
A detailed history of Peapod Lane Capital LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Peapod Lane Capital LLC holds 452,468 shares of AVIR stock, worth $1.59 Million. This represents 1.63% of its overall portfolio holdings.
Number of Shares
452,468
Previous 452,060
0.09%
Holding current value
$1.59 Million
Previous $1.35 Billion
20.51%
% of portfolio
1.63%
Previous 1.52%
Shares
3 transactions
Others Institutions Holding AVIR
# of Institutions
110Shares Held
48.9MCall Options Held
0Put Options Held
14.1K-
Black Rock Inc. New York, NY9.12MShares$32 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$26.7 Million20.73% of portfolio
-
Tang Capital Management LLC San Diego, CA4.89MShares$17.2 Million1.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$17.2 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$8.72 Million2.68% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $292M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...